Treatment of recurrent hepatitis C in liver transplant recipients

Clinical Gastroenterology and Hepatology

Volumn 3, Issue SUPPL. 2, 2005, Pages

  Terrault, Norah A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CIVACIR; HEPATITIS B ANTIBODY; HEPATITIS C IMMUNOGLOBULIN; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; RIBAVIRIN; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; CONFERENCE PAPER; CYTOPENIA; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; LIVER CIRRHOSIS; LIVER GRAFT; LIVING DONOR; RECURRENT DISEASE; SURVIVAL RATE;

ANTIVIRAL AGENTS; DISEASE PROGRESSION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; RECURRENCE;

EID: 26444440972     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00709-3     Document Type: Conference Paper

References (54)

1. L.M. Forman, J.D. Lewis, J.A. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
2. M. Berenguer, L. Ferrell, J. Watson HCV-related fibrosis progression following liver transplantation increase in recent years J Hepatol 32 2000 673 684
3. C. Feray, L. Caccamo, G.J. Alexander European collaborative study on factors influencing outcome after liver transplantation for hepatitis C European Concerted Action on Viral Hepatitis (EUROHEP) Group Gastroenterology 117 1999 619 625
4. E. Gane, B. Portmann, N. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815 820
5. U. Neumann, T. Berg, M. Bahra Fibrosis progression after liver transplantation in patients with recurrent hepatitis C J Hepatol 41 2004 830 836
6. M. Prieto, M. Berenguer, J. Rayon High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation relationship with rejection episodes Hepatology 29 1999 250 256
7. M. Berenguer, M. Prieto, J.M. Rayon Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 32 2000 852 858
8. D.N. Samonakis, C.K. Triantos, U. Thalheimer Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation Liver Transpl 11 2005 386 395
9. M. Berenguer, M. Prieto, F. San Juan Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202 210
10. J.R. Lake, J.S. Shorr, B.J. Steffen Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis Am J Transplant 5 2005 549 557
11. H. Rosen, C. Shackleton, L. Higa Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1997 1453 1457
12. R.J. Firpi, M.F. Abdelmalek, C. Soldevila-Pico One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection Liver Transpl 10 2004 1240 1247
13. M. Charlton, E. Seaberg, R. Wiesner Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 1998 823 830
14. M. Shiffman, R. Stravitz, M. Contos Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation Liver Transpl 10 2004 1248 1255
15. M. Garcia-Retortillo, X. Forns, J. Llovet Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation Hepatology 40 2004 699 707
16. P. Thuluvath, H. Yoo Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation Liver Transpl 10 2004 1263 1268
17. M. Russo, J. Galanko, K. Beavers Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States Liver Transpl 10 2004 340 346
18. P. Gaglio, S. Malireddy, B. Levitt Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors Liver Transpl 9 2003 1028 1035
19. H.R. Rosen, P. Martin Hepatitis C infection in patients undergoing liver retransplantation Transplantation 66 1998 1612 1616
20. G. Neff, C. O'Brien, J. Nery Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection Liver Transpl 10 2004 1497 1503
21. S. Biggins, N. Terrault Should HCV-related cirrhosis be a contraindication for retransplantation? Liver Transpl 9 2003 236 238
22. R. Wiesner, M. Sorrell, F. Villamil International Liver Transplantation Society Expert Panel Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C Liver Transpl 9 2003 S1 S9
23. J.S. Crippin, T. McCashland, N. Terrault A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation Liver Transpl 8 2002 350 355
24. G. Everson Treatment of patients with hepatitis C virus on the waiting list Liver Transpl 9 2003 S90 S94
25. M. Khalili, A. Vardanian, C. Hamerski Clinical management of hepatitis C-infected transplant recipients in North American transplant centers changes in recent years Clin Transpl 2005 (in press)
26. C. Feray, M. Gigou, D. Samuel Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation Ann Intern Med 128 1998 810 816
27. M.Y. Yu, B. Bartosch, P. Zhang Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma Proc Natl Acad Sci U S A 101 2004 7705 7710
28. D. Lavillette, Y. Morice, G. Germanidis Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection J Virol 79 2005 6023 6034
29. K. Krawczynski, M. Alter, D. Tankersley Effect of immune globulin on the prevention of experimental hepatitis C virus infection J Infect Dis 173 1996 822 828
30. B. Willems, P. Marotta, P.D. Greig Anti-HCV immunoglobulins for the prevention of graft infection in HCV-related liver transplantation J Hepatol 36 2002 S96A
31. G. Davis, D.R. Nelson, N. Terrault A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients Liver Transpl 11 2005 941 949
32. A. Shergill, M. Khalili, S. Straley Applicability, tolerability and efficacy of preemptive anviral therapy in hepatitis C infected patients undergoing liver transplantation Am J Transplant 5 2005 118 124
33. P. Sheiner, P. Boros, F. Klion The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 1998 831 838
34. N. Singh, T. Gayowski, C.F. Wannstedt Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients a prospective, randomized, controlled trial Transplantation 65 1998 82 86
35. N. Chalasani, C. Manzarbeitia, P. Ferenci Peginterferon alfa-2a for hepatitis C after liver transplantation two randomized, controlled trials Hepatology 41 2005 289 298
36. V. Mazzaferro, A. Tagger, M. Schiavo Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment Transplant Proc 33 2001 1355 1357
37. Y. Sugawara, M. Makuuchi, Y. Matsui Preemptive therapy for hepatitis C virus after living-donor liver transplantation Transplantation 78 2004 1308 1311
38. M. Berenguer, M. Prieto, A. Palau Recurrent hepatitis C genotype 1b following liver transplantation treatment with combination interferon-ribavirin therapy Eur J Gastroenterol Hepatol 16 2004 1207 1212
39. R. Firpi, M. Abdelmalek, C. Soldevila-Pico Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C Liver Transpl 8 2002 1000 1006
40. B. Lavezzo, A. Franchello, A. Smedile Treatment of recurrent hepatitis C in liver transplants efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin J Hepatol 37 2002 247 252
41. R. Stravitz, M. Shiffman, A. Sanyal Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation Liver Transpl 10 2004 850 858
42. T. Bizollon, U. Palazzo, C. Ducerf Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 1997 500 504
43. S. Mukherjee, E. Lyden, T.M. McCashland Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation cohort study of 38 patients J Gastroenterol Hepatol 20 2005 198 203
44. E. Giostra, G.A. Kullak-Ublick, W. Keller Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation Transpl Int 17 2004 169 176
45. K.V. Narayanan Menon, J.J. Poterucha, O.M. El-Amin Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin lessons on tolerability and efficacy Liver Transpl 8 2002 623 629
46. S. Nair, S. Khan, G. Loss Treatment of recurrent hepatitis C in liver transplant recipients is there any histologic benefit? Liver Transpl 9 2003 354 359
47. D. Samuel, T. Bizollon, C. Feray Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation a randomized study Gastroenterology 124 2003 642 650
48. A.O. Shakil, B. McGuire, J. Crippin A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C Hepatology 36 2002 1253 1258
49. L. Castells, V. Vargas, H. Allende Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation J Hepatol 43 2005 53 59
50. J. Dumortier, J. Scoazec, P. Chevallier Treatment of recurrent hepatitis C after liver transplantation a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 2004 669 674
51. S. Mukherjee, J. Rogge, L. Weaver Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation Transplant Proc 35 2003 3042 3044
52. P. Toniutto, C. Fabris, E. Fumo Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C comparison of tolerability and efficacy J Gastroenterol Hepatol 20 2005 577 582
53. A.S. Ross, A.K. Bhan, M. Pascual Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C Clin Transplant 18 2004 166 173
54. A. Regev, E. Molina, R. Moura Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation Liver Transpl 10 2004 1233 1239